Whether the preserved immune activation profile might be a consequence or cause of a low CD4/CD8 ratio is hard to determine, but all these studies together suggest that the CD4/CD8 ratio could be used as a an adequate biomarker for monitoring the state of immune dysfunction and morbidity/mortality in long-term treated HIV-infected subjects. Here, CD8A is linked to immune system disorder.